NABP Home Infusion Therapy Pharmacy Accreditation Consulting
CMS-Approved Accreditation for Pharmacies Providing Home Infusion Therapy Services to Medicare Beneficiaries
What Is NABP Home Infusion Therapy Pharmacy Accreditation?
NABP Home Infusion Therapy Pharmacy Accreditation is a CMS-approved accreditation program for pharmacies that furnish home infusion therapy services — intravenous drugs and biological products administered to patients in their homes — and wish to bill those services under Medicare Part B. CMS requires that pharmacies billing Medicare for the administration of home infusion therapy services in a patient's home hold accreditation from a CMS-approved accrediting organization. NABP is one of those CMS-approved organizations, offering a 3-year accreditation specifically designed for home infusion pharmacy practice.
Home infusion therapy involves the preparation and dispensing of complex parenteral medications — including antibiotics, antifungals, chemotherapy, total parenteral nutrition (TPN), pain management drugs, biologics, and inotropic agents — along with patient education, clinical monitoring, care coordination, and 24/7 clinical support. The complexity of home infusion practice, the vulnerability of the patient population, and the clinical risk inherent in parenteral drug administration make accreditation a meaningful patient safety standard, not just a billing requirement.
Who Needs Home Infusion Therapy Pharmacy Accreditation?
This accreditation is designed for pharmacies that meet both criteria: they furnish infusion therapy services to patients in the home, and they are seeking to bill or currently bill Medicare Part B for those services. Eligible pharmacy types include:
- Dedicated home infusion pharmacies — pharmacies whose primary business model is home infusion therapy preparation, dispensing, and clinical support
- Specialty pharmacies with home infusion lines — specialty pharmacies that have added home infusion therapy as a service line alongside other specialty drug programs
- Hospital outpatient pharmacies — hospital pharmacy departments that provide home infusion therapy services to patients transitioning from inpatient to home settings
- Long-term care infusion providers — pharmacies that provide infusion therapy to patients in assisted living, hospice, or other non-hospital settings that qualify under Medicare's home infusion benefit
A pharmacy that furnishes home infusion therapy services to patients but does not bill Medicare Part B is not federally required to hold this specific accreditation. However, many commercial insurers, Medicaid programs, and managed care organizations have adopted requirements aligned with CMS's accreditation standard, and some require accreditation as a condition of network participation regardless of Medicare billing.
The Medicare Home Infusion Therapy Benefit
The Medicare home infusion therapy benefit — established under the 21st Century Cures Act and implemented by CMS — covers the professional services component of home infusion therapy: the nursing and clinical services associated with the administration of covered home infusion drugs. The drug itself is typically billed under Medicare Part D (or the pharmacy benefit), while the administration and associated professional services are billed under Medicare Part B by an accredited home infusion therapy supplier.
Covered home infusion drugs under Part B include certain antibiotics, antifungals, antivirals, inotropic therapy drugs, and other categories designated by CMS. TPN and some other drug categories are covered through separate Medicare pathways. IHS helps home infusion pharmacies understand the intersection of Part B billing requirements and accreditation standards, including which drug categories trigger the accreditation requirement.
Accreditation is a prerequisite for enrollment with Medicare as a home infusion therapy supplier. Without accreditation, a pharmacy cannot enroll and cannot bill Medicare Part B for home infusion professional services — even if it is already enrolled as a pharmacy under Part D.
NABP Home Infusion Therapy Pharmacy Accreditation Standards
NABP's Home Infusion Therapy Pharmacy Accreditation standards are comprehensive and reflect the clinical complexity of home infusion practice. Key standard areas include:
24/7 Clinical Support Requirement
One of the most operationally demanding requirements: the pharmacy must ensure safe and effective provision and administration of home infusion therapy on a 7-day-a-week, 24-hour-a-day basis. This means pharmacist-on-call coverage around the clock, every day of the year, with the capacity to respond to clinical questions, adverse events, infusion device malfunctions, and urgent medication needs at any hour. Documenting and operationalizing this requirement is a primary focus of the accreditation readiness process.
Patient Assessment and Care Planning
The pharmacy must conduct patient assessments prior to initiating home infusion therapy and develop individualized care plans. Care plans must address the patient's diagnosis, prescribed therapy, venous access, clinical monitoring parameters, patient education needs, and coordination with the prescribing physician and other members of the care team. Assessment and care planning processes must be documented and consistently followed.
Sterile Compounding and USP Standards
Home infusion pharmacies preparing sterile parenteral products must comply with USP Chapter 797 standards for sterile compounding. This encompasses clean room design and environmental monitoring, beyond-use dating, personnel competency testing, quality assurance programs, and documentation requirements. For pharmacies also handling hazardous drugs (e.g., chemotherapy), USP Chapter 800 applies. IHS evaluates sterile compounding compliance as a core component of home infusion accreditation engagements.
Patient Education and Training
Patients or caregivers who will administer infusions at home must receive structured education and demonstrate competency in infusion technique, device operation, aseptic technique, recognition of adverse events, and emergency procedures. The pharmacy must document patient/caregiver education and competency assessment for every patient. Education programs must be tailored to patient literacy and language needs.
Clinical Monitoring and Outcome Tracking
The pharmacy must maintain ongoing clinical monitoring of patients receiving home infusion therapy, including monitoring for drug-related complications, adverse events, and therapy outcomes. Monitoring findings must be documented and communicated to the prescribing physician and care team. The pharmacy must maintain a quality assurance program that tracks outcomes and uses data for continuous improvement.
Infusion Equipment and Supply Management
The pharmacy must maintain appropriate infusion pumps, accessories, and supplies for the therapies it provides. Equipment must be inspected, calibrated, and maintained in accordance with manufacturer specifications. The pharmacy must have processes for managing pump malfunctions, recalls, and urgent equipment replacement for patients mid-therapy.
Coordination with Prescribers and Care Team
Home infusion therapy requires close coordination with the prescribing physician, nursing services, and other members of the patient's care team. The pharmacy must have documented processes for communicating clinical findings, therapy changes, and adverse events to the prescriber and, where applicable, to home health nurses or other clinical partners.
Annual Compliance Review
NABP Home Infusion Therapy Pharmacy Accreditation is issued for a 3-year term. During years 2 and 3, NABP requires an annual compliance review. Prior to the accreditation cycle anniversary date in years 2 and 3, NABP contacts the pharmacy to initiate the review and provides guidelines. IHS helps clients prepare for annual compliance reviews and maintain ongoing readiness throughout the accreditation cycle — not just at initial accreditation and reaccreditation.
How IHS Supports Home Infusion Therapy Pharmacy Accreditation
Thomas G. Goddard, JD, PhD — IHS's principal consultant and former Chief Operating Officer and General Counsel of URAC — leads every home infusion accreditation engagement with direct attention to the clinical, operational, and regulatory complexity of home infusion pharmacy practice.
Gap Assessment
IHS conducts a comprehensive gap assessment against NABP's Home Infusion Therapy Pharmacy Accreditation standards, with particular attention to 24/7 coverage infrastructure, sterile compounding compliance, patient education programs, and clinical monitoring systems. The gap assessment produces a prioritized remediation roadmap.
Policy, SOP, and Program Development
IHS develops or revises the full policy and procedure infrastructure required for accreditation, including patient assessment and care planning processes, 24/7 on-call coverage protocols, sterile compounding SOPs (aligned with USP 797/800), patient education programs, clinical monitoring workflows, equipment management procedures, and quality assurance programs.
Sterile Compounding Compliance Review
Given the centrality of sterile compounding compliance to home infusion pharmacy operations and accreditation, IHS conducts a focused review of USP 797/800 compliance status, including environmental monitoring data, beyond-use dating practices, personnel competency records, and clean room documentation. Gaps in sterile compounding compliance are prioritized in the remediation roadmap.
Pre-Accreditation Mock Review and Application Support
Before submitting the NABP application, IHS conducts a comprehensive pre-accreditation review. Application preparation and submission are supported by IHS throughout the process, including response to any NABP requests for additional information.
Ready to Pursue Home Infusion Therapy Pharmacy Accreditation?
Whether you are a new home infusion pharmacy building your compliance program from the ground up or an established operation preparing for reaccreditation, IHS provides the structured consulting expertise you need. Thomas G. Goddard, JD, PhD is personally engaged in every IHS accreditation engagement.
Schedule a Free Discovery Session